Business Description
Description
Sunho Biologics Inc is a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of biologics for the treatment of cancers and autoimmune diseases. It has three Core Products, IAH0968, IAP0971, and IAE0972, all of which are developed in-house. IAH0968 is an antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced monoclonal antibody (mAb), and the company has initiated Phase II clinical trials for biliary tract carcinoma (BTC) and colorectal cancer (CRC). IAP0971 and IAE0972 are both immunocytokines and It has completed Phase I clinical trials for advanced solid tumors including non-small cell lung cancer (NSCLC) and CRC.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 23.15 | |||||
| Equity-to-Asset | -0.36 | |||||
| Debt-to-Equity | -0.09 | |||||
| Debt-to-EBITDA | -0.26 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.46 | |||||
| 9-Day RSI | 27.85 | |||||
| 14-Day RSI | 33.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.59 | |||||
| Quick Ratio | 0.58 | |||||
| Cash Ratio | 0.54 | |||||
| Days Inventory | 4453.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 66.23 | |||||
| Operating Margin % | -31795.18 | |||||
| Net Margin % | -63660.53 | |||||
| FCF Margin % | -19996.49 | |||||
| ROA % | -19.57 | |||||
| ROIC % | -23.16 | |||||
| ROC (Joel Greenblatt) % | -71.32 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5800 | |||||
| EV-to-EBIT | -17.78 | |||||
| EV-to-EBITDA | -17.78 | |||||
| EV-to-Revenue | 2981.01 | |||||
| EV-to-FCF | -14.91 | |||||
| Earnings Yield (Greenblatt) % | -5.62 | |||||
| FCF Yield % | -5.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sunho Biologics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 0.228 | ||
| EPS (TTM) (HK$) | -1.292 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 33.79 | ||
| 14-Day ATR (HK$) | 0.20048 | ||
| 20-Day SMA (HK$) | 6.327 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (HK$) | 4.2 - 15.42 | ||
| Shares Outstanding (Mil) | 156.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sunho Biologics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sunho Biologics Inc Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sunho Biologics Inc Frequently Asked Questions
What is Sunho Biologics Inc(HKSE:02898)'s stock price today?
The current price of HKSE:02898 is HK$5.80. The 52 week high of HKSE:02898 is HK$15.42 and 52 week low is HK$4.20.
When is next earnings date of Sunho Biologics Inc(HKSE:02898)?
The next earnings date of Sunho Biologics Inc(HKSE:02898) is .
Does Sunho Biologics Inc(HKSE:02898) pay dividends? If so, how much?
Sunho Biologics Inc(HKSE:02898) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers